{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:11:32Z","timestamp":1791141092258,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostate International"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.prnil.2024.03.002","type":"journal-article","created":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T01:15:56Z","timestamp":1710638156000},"page":"117-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Current status and therapeutic value of extended pelvic lymph node dissection during radical prostatectomy for prostate cancer"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0344-5892","authenticated-orcid":false,"given":"Shuichi","family":"Morizane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prnil.2024.03.002_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.prnil.2024.03.002_bib2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.1995.03520310046028","article-title":"The role of increasing detection in the rising incidence of prostate cancer","volume":"273","author":"Potosky","year":"1995","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.prnil.2024.03.002_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: Screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.prnil.2024.03.002_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2019.0023","article-title":"Prostate cancer, Version 2.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Mohler","year":"2019","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"issue":"1","key":"10.1016\/j.prnil.2024.03.002_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.urology.2006.01.055","article-title":"Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer","volume":"68","author":"Joslyn","year":"2006","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.prnil.2024.03.002_bib6","first-page":"1510","article-title":"Contemporary incidence and outcomes of prostate cancer lymph node metastases","volume":"199","author":"Bernstein","year":"2018","journal-title":"J\u00a0Urol"},{"issue":"11","key":"10.1016\/j.prnil.2024.03.002_bib7","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D'Amico","year":"1998","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.prnil.2024.03.002_bib8","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/iju.12112","article-title":"Is pelvic lymph node dissection required at radical prostatectomy for low-risk prostate cancer?","volume":"20","author":"Mitsuzuka","year":"2013","journal-title":"Int J Urol"},{"issue":"9","key":"10.1016\/j.prnil.2024.03.002_bib9","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1089\/end.2011.0589","article-title":"Does pelvic lymph node dissection improve the biochemical relapse-free survival in low-risk prostate cancer patients treated by laparoscopic radical prostatectomy?","volume":"26","author":"Daimon","year":"2012","journal-title":"J\u00a0Endourol"},{"issue":"2","key":"10.1016\/j.prnil.2024.03.002_bib10","doi-asserted-by":"crossref","first-page":"81 e17","DOI":"10.1016\/j.urolonc.2017.10.022","article-title":"Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification","volume":"36","author":"Leyh-Bannurah","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.prnil.2024.03.002_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.urology.2016.02.046","article-title":"The role of pelvic lymph node dissection during radical prostatectomy in patients with gleason 6 intermediate-risk prostate cancer","volume":"93","author":"Mandel","year":"2016","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.prnil.2024.03.002_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/iju.15075","article-title":"Clinical significance of limited and extended pelvic lymph node dissection during robot-assisted radical prostatectomy for patients with localized prostate cancer: A retrospective, propensity score matching analysis","volume":"30","author":"Hori","year":"2023","journal-title":"Int J Urol"},{"issue":"9","key":"10.1016\/j.prnil.2024.03.002_bib13","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ejso.2013.12.016","article-title":"The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the \"post-dissemination\" period","volume":"40","author":"Gandaglia","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.prnil.2024.03.002_bib14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.eururo.2007.03.064","article-title":"Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer","volume":"53","author":"Jeschke","year":"2008","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.prnil.2024.03.002_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.crad.2007.05.022","article-title":"The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis","volume":"63","author":"Hovels","year":"2008","journal-title":"Clin Radiol"},{"issue":"4","key":"10.1016\/j.prnil.2024.03.002_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2020.151044","article-title":"PSMA PET scan era: A changing paradigm PSMA PET and lymph node dissection for prostate cancer management","volume":"36","author":"Haxhimolla","year":"2020","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.prnil.2024.03.002_bib17","article-title":"Head-to-head comparison of (68)Ga-PSMA-11 PET\/CT and multiparametric MRI for pelvic lymph node staging prior to radical prostatectomy in patients with intermediate to high-risk prostate cancer: a meta-analysis","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.prnil.2024.03.002_bib18","first-page":"1798","article-title":"A\u00a0preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer","volume":"170","author":"Cagiannos","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.prnil.2024.03.002_bib19","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.eururo.2011.11.008","article-title":"Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.prnil.2024.03.002_bib20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.eururo.2018.10.012","article-title":"A\u00a0novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies","volume":"75","author":"Gandaglia","year":"2019","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.prnil.2024.03.002_bib21","article-title":"Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database","volume":"9","author":"Chen","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.prnil.2024.03.002_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prnil.2023.07.004","article-title":"Prostate cancer nomograms and their application in Asian men: a review","volume":"12","author":"Panaiyadiyan","year":"2024","journal-title":"Prostate International"},{"issue":"3","key":"10.1016\/j.prnil.2024.03.002_bib23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2011.10.044","article-title":"Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.prnil.2024.03.002_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.6004\/jnccn.2010.0012","article-title":"NCCN clinical practice guidelines in oncology: prostate cancer","volume":"8","author":"Mohler","year":"2010","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"issue":"4","key":"10.1016\/j.prnil.2024.03.002_bib25","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10147-022-02121-z","article-title":"Extent of pelvic lymph node dissection improves early oncological outcomes for patients with high-risk prostate cancer without lymph node involvement after robot-assisted radical prostatectomy","volume":"27","author":"Morizane","year":"2022","journal-title":"Int J Clin Oncol"},{"issue":"8","key":"10.1016\/j.prnil.2024.03.002_bib26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/iju.15195","article-title":"Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era","volume":"30","author":"Goto","year":"2023","journal-title":"Int J Urol"},{"issue":"18","key":"10.1016\/j.prnil.2024.03.002_bib27","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.1997.03540420041027","article-title":"Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update","volume":"277","author":"Partin","year":"1997","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.prnil.2024.03.002_bib28","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.urology.2007.03.042","article-title":"Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005","volume":"69","author":"Makarov","year":"2007","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.prnil.2024.03.002_bib29","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.eururo.2006.01.043","article-title":"Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy","volume":"49","author":"Briganti","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.prnil.2024.03.002_bib30","series-title":"Pre-Radical Prostatectomy Tool to Predict Probability of Lymph Node Involvement in Prostate Cancer Patients","year":"2020"},{"issue":"1","key":"10.1016\/j.prnil.2024.03.002_bib31","first-page":"19","article-title":"External validation of Memorial Sloan Kettering Cancer Center nomogram and prediction of optimal candidate for lymph node dissection in clinically localized prostate cancer","volume":"73","author":"Milonas","year":"2020","journal-title":"Cent European J Urol"},{"issue":"6","key":"10.1016\/j.prnil.2024.03.002_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061683","volume":"15","author":"Di Pierro","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.prnil.2024.03.002_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/21681805.2017.1332680","article-title":"Comparison between Briganti, Partin and MSKCC tools in predicting positive lymph nodes in prostate cancer: a systematic review and meta-analysis","volume":"51","author":"Cimino","year":"2017","journal-title":"Scand J Urol"},{"issue":"4","key":"10.1016\/j.prnil.2024.03.002_bib34","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.eururo.2013.12.059","article-title":"Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions","volume":"66","author":"Suardi","year":"2014","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.prnil.2024.03.002_bib35","first-page":"191","article-title":"Differences in rates of pelvic lymph node dissection in National Comprehensive Cancer Network favorable, unfavorable intermediate- and high-risk prostate cancer across United States SEER registries","volume":"16","author":"Flammia","year":"2022","journal-title":"Curr Urol"},{"issue":"3","key":"10.1016\/j.prnil.2024.03.002_bib36","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s10147-017-1223-x","article-title":"Comparison of the diagnostic efficacy and perioperative outcomes of limited versus extended pelvic lymphadenectomy during robot-assisted radical prostatectomy: a multi-institutional retrospective study in Japan","volume":"23","author":"Morizane","year":"2018","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"10.1016\/j.prnil.2024.03.002_bib37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eururo.2013.03.057","article-title":"Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature","volume":"65","author":"Ploussard","year":"2014","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.prnil.2024.03.002_bib38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.eururo.2016.12.003","article-title":"The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review","volume":"72","author":"Fossati","year":"2017","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.prnil.2024.03.002_bib39","doi-asserted-by":"crossref","first-page":"29 e21","DOI":"10.1016\/j.urolonc.2012.10.009","article-title":"Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection","volume":"32","author":"Passoni","year":"2014","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.prnil.2024.03.002_bib40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.prnil.2022.12.005","article-title":"Extended versus standard pelvic lymph node dissection yields no difference in 3-year biochemical recurrence rates","volume":"11","author":"Nagaya","year":"2023","journal-title":"Prostate Int"},{"issue":"2","key":"10.1016\/j.prnil.2024.03.002_bib41","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1464-410X.2012.11765.x","article-title":"Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis","volume":"112","author":"Kim","year":"2013","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.prnil.2024.03.002_bib42","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12957-023-02932-y","article-title":"Different lymph node dissection ranges during radical prostatectomy for patients with prostate cancer: a systematic review and network meta-analysis","volume":"21","author":"Zhang","year":"2023","journal-title":"World J Surg Oncol"},{"issue":"2","key":"10.1016\/j.prnil.2024.03.002_bib43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.euo.2021.02.001","article-title":"Impact of pelvic lymph node dissection and its extent on perioperative morbidity in patients undergoing radical prostatectomy for prostate cancer: a comprehensive systematic review and meta-analysis","volume":"4","author":"Cacciamani","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"7","key":"10.1016\/j.prnil.2024.03.002_bib44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11934-017-0696-5","article-title":"Therapeutic value of standard versus extended pelvic lymph node dissection during radical prostatectomy for high-risk prostate cancer","volume":"18","author":"Colicchia","year":"2017","journal-title":"Curr Urol Rep"},{"issue":"1","key":"10.1016\/j.prnil.2024.03.002_bib45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/bju.14164","article-title":"Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection","volume":"122","author":"Altok","year":"2018","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.prnil.2024.03.002_bib46","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.euo.2021.03.006","article-title":"Limited versus extended pelvic lymph node dissection for prostate cancer: a randomized clinical trial","volume":"4","author":"Touijer","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"11","key":"10.1016\/j.prnil.2024.03.002_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112696","article-title":"Current status and future perspective on the management of lymph node-positive prostate cancer after radical prostatectomy","volume":"14","author":"Shiota","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.prnil.2024.03.002_bib48","doi-asserted-by":"crossref","DOI":"10.1007\/s11934-013-0377-y","article-title":"Perioperative complications of robot-assisted partial nephrectomy","volume":"15","author":"Kim","year":"2013","journal-title":"Curr Urol Rep"},{"issue":"3","key":"10.1016\/j.prnil.2024.03.002_bib49","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.urology.2013.03.086","article-title":"Anatomic extent of pelvic lymph node dissection: impact on long-term cancer-specific outcomes in men with positive lymph nodes at time of radical prostatectomy","volume":"82","author":"Bivalacqua","year":"2013","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.prnil.2024.03.002_bib50","first-page":"9340","article-title":"Biochemical recurrence after robot-assisted extended pelvic lymphadenectomy for prostate cancer","volume":"25","author":"Chenam","year":"2018","journal-title":"Can J Urol"},{"issue":"5","key":"10.1016\/j.prnil.2024.03.002_bib51","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.eururo.2020.11.040","article-title":"Extended versus limited pelvic lymph node dissection during radical prostatectomy for intermediate- and high-risk prostate cancer: early oncological outcomes from a randomized phase 3 trial","volume":"79","author":"Lestingi","year":"2021","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.prnil.2024.03.002_bib52","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.eururo.2013.05.026","article-title":"The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review","volume":"65","author":"Yuh","year":"2014","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.prnil.2024.03.002_bib53","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1007\/s10147-020-01682-1","article-title":"Small-volume lymph node involvement and biochemical recurrence after robot-assisted radical prostatectomy with extended lymph node dissection in prostate cancer","volume":"25","author":"Morizane","year":"2020","journal-title":"Int J Clin Oncol"},{"issue":"11","key":"10.1016\/j.prnil.2024.03.002_bib54","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00345-015-1515-6","article-title":"Robotic-assisted pelvic lymph node dissection for prostate cancer: frequency of nodal metastases and oncological outcomes","volume":"33","author":"Ledezma","year":"2015","journal-title":"World J Urol"},{"issue":"15","key":"10.1016\/j.prnil.2024.03.002_bib55","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/pros.22702","article-title":"Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: the Johns Hopkins hospital 30-year experience","volume":"73","author":"Pierorazio","year":"2013","journal-title":"Prostate"},{"issue":"2-3","key":"10.1016\/j.prnil.2024.03.002_bib56","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.euf.2016.02.018","article-title":"Association between Lymph Node Counts and Oncological Outcomes in Lymph Node Positive Prostate Cancer","volume":"3","author":"Mandel","year":"2017","journal-title":"European Urology Focus"},{"issue":"2","key":"10.1016\/j.prnil.2024.03.002_bib57","first-page":"338","article-title":"Effect of extended pelvic lymph node dissection on oncologic outcomes in patients with D'Amico intermediate and high risk prostate cancer treated with radical prostatectomy: a multi-institutional study","volume":"203","author":"Preisser","year":"2020","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.prnil.2024.03.002_bib58","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/pros.23491","article-title":"Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion","volume":"78","author":"Preisser","year":"2018","journal-title":"Prostate"},{"issue":"8","key":"10.1016\/j.prnil.2024.03.002_bib59","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1464-410X.2010.10016.x","article-title":"The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer","volume":"108","author":"Schiavina","year":"2011","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.prnil.2024.03.002_bib60","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.eururo.2014.05.011","article-title":"More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer","volume":"67","author":"Abdollah","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.prnil.2024.03.002_bib61","article-title":"Identifying the candidates who will benefit from extended pelvic lymph node dissection at radical prostatectomy among patients with prostate cancer","volume":"11","author":"Yang","year":"2021","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.prnil.2024.03.002_bib62","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1245\/s10434-017-5822-6","article-title":"Extended versus standard pelvic lymph node dissection in radical prostatectomy on oncological and functional outcomes: a systematic review and meta-analysis","volume":"24","author":"Choo","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.prnil.2024.03.002_bib63","first-page":"2082","article-title":"Pelvic lymph node dissection for prostate cancer: frequency and distribution of nodal metastases in a contemporary radical prostatectomy series","volume":"187","author":"Godoy","year":"2012","journal-title":"J\u00a0Urol"},{"issue":"8","key":"10.1016\/j.prnil.2024.03.002_bib64","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1089\/lap.2011.0516","article-title":"Extended pelvic lymph node dissection including internal iliac packet should be performed during robot-assisted laparoscopic radical prostatectomy for high-risk prostate cancer","volume":"22","author":"Jung","year":"2012","journal-title":"J\u00a0Laparoendosc Adv Surg Tech"},{"issue":"1","key":"10.1016\/j.prnil.2024.03.002_bib65","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1634\/theoncologist.2008-0123","article-title":"Indications, extent, and benefits of pelvic lymph node dissection for patients with bladder and prostate cancer","volume":"14","author":"Thurairaja","year":"2009","journal-title":"Oncol"},{"issue":"4","key":"10.1016\/j.prnil.2024.03.002_bib66","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.eururo.2017.03.049","article-title":"Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer","volume":"72","author":"Gandaglia","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.prnil.2024.03.002_bib67","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3389\/fonc.2019.01395","article-title":"The role of radical prostatectomy and lymph node dissection in clinically node positive patients","volume":"9","author":"Motterle","year":"2019","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.prnil.2024.03.002_bib68","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.eururo.2020.01.033","article-title":"Benefits and risks of primary treatments for high-risk localized and locally advanced prostate cancer: an international multidisciplinary systematic review","volume":"77","author":"Moris","year":"2020","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.prnil.2024.03.002_bib69","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.eururo.2013.03.053","article-title":"Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy","volume":"65","author":"Touijer","year":"2014","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.prnil.2024.03.002_bib70","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.eururo.2011.10.010","article-title":"Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy","volume":"61","author":"Stephenson","year":"2012","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.prnil.2024.03.002_bib71","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11864-004-0026-2","article-title":"Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy","volume":"5","author":"Stephenson","year":"2004","journal-title":"Curr Treat Options Oncol"},{"issue":"18","key":"10.1016\/j.prnil.2024.03.002_bib72","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1200\/JCO.2008.18.9563","article-title":"Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02\/AUO AP 09\/95","volume":"27","author":"Wiegel","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.prnil.2024.03.002_bib73","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(06)70700-8","article-title":"Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy","volume":"7","author":"Messing","year":"2006","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.prnil.2024.03.002_bib74","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1111\/cas.15383","article-title":"Radiotherapy plus androgen deprivation therapy for prostate-specific antigen persistence in lymph node-positive prostate cancer","volume":"113","author":"Shiota","year":"2022","journal-title":"Cancer Sci"},{"issue":"66","key":"10.1016\/j.prnil.2024.03.002_bib75","doi-asserted-by":"crossref","first-page":"110625","DOI":"10.18632\/oncotarget.22610","article-title":"Lymph node ratio determines the benefit of adjuvant radiotherapy in pathologically 3 or less lymph node-positive prostate cancer after radical prostatectomy: a population-based analysis with propensity-score matching","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.prnil.2024.03.002_bib76","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.eururo.2017.09.027","article-title":"Survival outcomes of men with lymph node-positive prostate cancer after radical prostatectomy: a comparative analysis of different postoperative management strategies","volume":"73","author":"Touijer","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.prnil.2024.03.002_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154415","article-title":"Radical prostatectomy findings in patients with locally aggressive grade group 5 prostatic adenocarcinoma and negative limited or extended pelvic lymph node dissection","volume":"244","author":"Mallikarjunappa","year":"2023","journal-title":"Pathol Res Pract"},{"issue":"2","key":"10.1016\/j.prnil.2024.03.002_bib78","doi-asserted-by":"crossref","first-page":"130 e1","DOI":"10.1016\/j.urolonc.2020.08.035","article-title":"Pathologic nodal downstaging in men with clinically involved lymph nodes undergoing radical prostatectomy: Implications for definitive locoregional therapy","volume":"39","author":"Ghali","year":"2021","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.prnil.2024.03.002_bib79","doi-asserted-by":"crossref","first-page":"115.e9","DOI":"10.1016\/j.urolonc.2023.12.016","article-title":"Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PET","volume":"42","author":"Huebner","year":"2024","journal-title":"Urol Oncol"}],"container-title":["Prostate International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888224000229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888224000229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T22:19:27Z","timestamp":1726611567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2287888224000229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2287888224000229"],"URL":"https:\/\/doi.org\/10.1016\/j.prnil.2024.03.002","relation":{},"ISSN":["2287-8882"],"issn-type":[{"value":"2287-8882","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current status and therapeutic value of extended pelvic lymph node dissection during radical prostatectomy for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Prostate International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prnil.2024.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Asian Pacific Prostate Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}